Collegium Pharmaceutical (COLL) Equity Ratio: 2016-2025
Historic Equity Ratio for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to 0.17.
- Collegium Pharmaceutical's Equity Ratio rose 19.33% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year increase of 19.33%. This contributed to the annual value of 0.14 for FY2024, which is 19.53% down from last year.
- According to the latest figures from Q3 2025, Collegium Pharmaceutical's Equity Ratio is 0.17, which was up 17.26% from 0.15 recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's Equity Ratio registered a high of 0.35 during Q2 2021, and its lowest value of 0.14 during Q4 2024.
- For the 3-year period, Collegium Pharmaceutical's Equity Ratio averaged around 0.16, with its median value being 0.15 (2023).
- In the last 5 years, Collegium Pharmaceutical's Equity Ratio skyrocketed by 47.24% in 2021 and then plummeted by 55.25% in 2022.
- Collegium Pharmaceutical's Equity Ratio (Quarterly) stood at 0.29 in 2021, then crashed by 43.40% to 0.17 in 2022, then increased by 3.01% to 0.17 in 2023, then fell by 19.53% to 0.14 in 2024, then grew by 19.33% to 0.17 in 2025.
- Its Equity Ratio stands at 0.17 for Q3 2025, versus 0.15 for Q2 2025 and 0.14 for Q1 2025.